You are here: Industry Insights > Takeda

News List

Takeda named under ‘Top Employers in 2021’ in India expresspharma
January 26, 2021
Takeda India has been named a Top Employer in 2021 by Top Employers Institute. This is also the fourth year in a row Takeda has received the global Top Employer status.
Takeda's Entyvio SC and Celltrion's Remsima SC EU5 Launches Have Benefitted from Parent Brand Reputation, New Clinical Data, and COVID-19 Restraints, According to Spherix Global Insights prnewswire
January 21, 2021
Two 2020 European Medical Agency (EMA) approvals, Takeda's Entyvio SC and Celltrion Healthcare's infliximab biosimilar, Remsima SC, have captured notable shares among EU5 IBD patients, according to Spherix's recent report, RealTime Dynamix™ ...
KSQ partners with Takeda to develop immuno-oncology therapies pharmaceutical-business-review
January 18, 2021
KSQ Therapeutics has joined forces with Japan-based Takeda Pharmaceutical to research, develop, and commercialise novel immuno-oncology therapies.
HemoShear Identifies Novel Drug Target to Treat NASH in Partnership with Takeda americanpharmaceuticalreview
December 31, 2020
HemoShear Therapeutics has achieved a research milestone in its discovery and development collaboration with Takeda Pharmaceutical to advance its first nonalcoholic steatohepatitis (NASH) target into Takeda's discovery portfolio.
Takeda to divest select assets in China to Hasten Biopharmaceutic for $322 mn expresspharma
December 22, 2020
Takeda Pharmaceutical Company has entered into an agreement to divest a portfolio of non-core prescription pharma products sold in China to Hasten Biopharmaceutic (China).
Pandemic has made little positive impact on public's view of pharma pharmatimes
December 16, 2020
Contrary to popular belief COVID-19 has actually had little positive impact on perceptions of pharmaceutical companies, finds a new report launched by Takeda UK.
Crescendo Biologics expands Takeda collaboration pharmatimes
December 11, 2020
Cambridge, UK-based Crescendo Biologics will expand its discovery and development collaboration with Japanese pharma company Takeda, which is focused on building Humabody-based therapeutics against undisclosed targets.
Takeda sells select products to Celltrion in Asia Pacific pharmaceutical-technology
December 02, 2020
Takeda Pharmaceutical Company has completed the previously announced sale of a portfolio of select products to South Korean biopharma firm Celltrion for $278m, including milestone payments.
XOMA Earns $2M Takeda Milestone contractpharma
November 18, 2020
XOMA Corp. has earned a $2 million milestone payment from Takeda Pharmaceutical Company as the first patient has been dosed in its Phase 2 study to evaluate safety, tolerability, and efficacy of mezagitamab (TAK-079) in generalized myasthenia gravis.
OrigiMed and Takeda Announced Partnership to Accelerate R&D and Commercialization of Innovative Medicines prnasia
November 12, 2020
OrigiMed, a China-based leading precision medicine company and Takeda, a global biopharmaceutical company announced their strategic partnership to develop a genomic-based precision medicine platform during the 3rd China International Import Expo.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 28 29 Next page